Emageon
Emageon (Booth 8537) is featuring its new Outside Study Gateway that offers a solution that enables outside facilities to perform direct DICOM transmission of their PACS images to the receiving hospital’s OSG server, providing for patient and exam integrity checks to be automatically performed as well as auto-forwarding into the receiving hospital’s enterprise PACS.
The studies are transmitted securely across a VPN network and automatically segregated. These automatic integrity checks avoid potential overlaps in patient IDs that could occur by combining data from multiple sites. Authorized physicians can then view these studies immediately using their existing PACS workstations and the toolsets with which they are familiar.
This solution allows side-by-side comparisons of additional exams performed with the outside exams done at the remote facility. The Emageon OSG also has the capacity for new studies to be provided back securely and electronically to the referring facility.
In early October, Emageon signed a definitive agreement with Health Systems Solutions (HHS) to sell 100 percent of Emageon’s stock, in an all cash transaction of approximately $62 million. The agreement was approved by HHS’ board of directors as well as Emageon’s Strategic Alternatives Committee. The merger—which is expected to close by March 31 or sooner—will result in a company of approximately 400 employees.
The studies are transmitted securely across a VPN network and automatically segregated. These automatic integrity checks avoid potential overlaps in patient IDs that could occur by combining data from multiple sites. Authorized physicians can then view these studies immediately using their existing PACS workstations and the toolsets with which they are familiar.
This solution allows side-by-side comparisons of additional exams performed with the outside exams done at the remote facility. The Emageon OSG also has the capacity for new studies to be provided back securely and electronically to the referring facility.
In early October, Emageon signed a definitive agreement with Health Systems Solutions (HHS) to sell 100 percent of Emageon’s stock, in an all cash transaction of approximately $62 million. The agreement was approved by HHS’ board of directors as well as Emageon’s Strategic Alternatives Committee. The merger—which is expected to close by March 31 or sooner—will result in a company of approximately 400 employees.